Changing Right-to-Try Laws in Montana

This chapter explores the recent expansion of right-to-try legislation in Montana, allowing broader access to experimental treatments beyond terminal patients. It examines the implications for medical freedom and patient choice, while addressing the potential risks involved with bypassing traditional regulatory safeguards. The discussion raises ethical concerns about the intersection of desperation for unapproved treatments and the interests of those seeking innovative therapies, highlighting the delicate balance between advancing healthcare and ensuring patient safety.